Eight Exceptional Reasons to Partner with Oximio for Your Clinical Trial in sub-Saharan Africa
Africa – the second largest continent in the world in terms of size and population. It is no surprise therefore, that it contains almost 25% of all infections in the world. With a genetically diverse population rising towards 2 billion in the next few years, tackling this significant disease burden is a major requirement. In Sub-Saharan Africa, clinical trials present unique challenges and opportunities due to the continent’s diverse landscape, regulatory environments and urgent medical needs.
At Oximio, we are working at the forefront of reshaping the clinical trial landscape in this region by way of innovative solutions and a robust infrastructure to streamline processes and enhance outcomes.
In this quick overview, we look at the top reasons to partner with Oximio for clinical trials in sub-Saharan Africa.
1. Collaborating for Success
Working alongside regulatory bodies such as the African Vaccine Regulatory Forum (AVAREF) and African Medicines Agency (AMA) customers will benefit from improved turn-around times for regulatory approvals, consistent, quality standards and medicines, capacity building and pharmacovigilance.
Via the Clinical Trials Community (CTC) platform partnership, Oximio can help sponsors gain access to African clinical trial sites, feasibility data and regulatory and ethics information all on one, easy-to-navigate, convenient platform.
By working closely with the Clinical Research Society of Kenya (CRSK), a non-profit organisation representing the clinical research community in Kenya, Oximio and other industry peers can have their say. Acting as a conduit serving and leading members through best practices and knowledge exchange, the CRSK, helps drive positive change and growth within the industry at a local level.
2. Extensive Regulatory Knowledge
Our pro-active regulatory adoption ensures that we stay informed about each country’s customs processes and regulatory changes, ensuring compliance and avoiding delays. This means that we are quickly able to adapt to any regulatory changes, minimising supply chain risk and ensuring efficient supply chain operations.
3. Multilingual Support
Operating across multiple countries means having to deal with multiple languages. Our team of experts provide multilingual support ensuring that documents, submissions and product labels are accurately translated and accepted across all countries.
4. Enhanced Technological Connectivity
By utilising satellite-based internet technology, such as Starlink, sponsors and patients benefit from high-speed internet access to remote and under-served areas, enhancing communication, patient engagement and data collection.
5. State of the art warehouses and customs bonded facilities
Our state-of-the-art storage and distribution services, provide safe and rapid movement of clinical trial materials and biospecimens.
Our bonded warehouse in Kenya provides sponsors with fiscal advantages granted by customs authorities such as the deferment of customs duties and taxes until the goods are released from the warehouse. In addition, customs documentation is handled as part of the service provided by the warehouse operator.
6. Dry Ice Shipping
By utilising dry-ice shipping vessels, valuable biospecimens, can be reliably and efficiently transported over long distances whilst ensuring they remain in a stable, frozen state, safeguarding the efficacy of the sample. Oximio provides dry ice shipping services to ensure sample safety across Africa with CryoSure®, the dry ice shipping solution by Envirotainer. Offering an easy and safe dry ice transportation dewar, Cryosure® is ISTA 7D validated for temperatures below -70°C for up to 21 days depending on size.
7. Medical Cannabis Distribution
With the attainment of an additional resolution to the SAPHRA Licence, Oximio, South Africa can accept medical cannabis for storage on behalf of local manufacturers and cultivators, placing it as a premier distributor for medical cannabis products for commercial of clinical trial purposes from Africa.
8. IN2Africa
This new initiative from Oximio provides a one-stop shop for supply chain co-ordination across sub-Saharan Africa, reducing risks and streamlining logistics.
Partner with Oximio in Africa
Partner with Oximio to navigate the complexities of clinical trials in sub-Saharan Africa. Leverage our expertise, innovative solutions and robust infrastructure to enhance your clinical trial outcomes and bring life-saving treatments to those who need them most. Contact us today to find out how we can support your clinical trial needs in Africa.